Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients

Vera, Ruth; Otero, M. J.; Ayala de la Peña, Francisco; González-Pérez, C.; Peñuelas Saiz, Angeles; Sepúlveda, Juan Manuel; Gorgas Torner, Maria Queralt

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Vera, Ruth
dc.contributor.author	Otero, M. J.
dc.contributor.author	Ayala de la Peña, Francisco
dc.contributor.author	González-Pérez, C.
dc.contributor.author	Peñuelas Saiz, Angeles
dc.contributor.author	Sepúlveda, Juan Manuel
dc.contributor.author	Gorgas Torner, Maria Queralt
dc.date.accessioned	2021-03-15T12:11:13Z
dc.date.available	2021-03-15T12:11:13Z
dc.date.issued	2019-04
dc.identifier.citation	Vera R, Otero MJ, Ayala de la Peña F, González-Pérez C, Peñuelas, Sepúlveda JM, et al. Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients. Clin Transl Oncol. 2019 Apr;21(4):467–78.
dc.identifier.issn	1699-3055
dc.identifier.uri	https://hdl.handle.net/11351/5756
dc.description	Errors de medicació; Prevenció i control; Seguretat del pacient
dc.description.sponsorship	This project was supported with unrestricted grants from SEFH and SEOM
dc.language.iso	eng
dc.publisher	Springer
dc.relation.ispartofseries	Clinical and Translational Oncology;21(4)
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Medicaments antineoplàstics
dc.subject	Oncologia
dc.subject	Errors de medicació
dc.subject.mesh	Antineoplastic Agents
dc.subject.mesh	/adverse effects
dc.subject.mesh	Medical Oncology
dc.subject.mesh	Medication Errors
dc.title	Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1007/s12094-018-1945-x
dc.subject.decs	antibióticos antineoplásicos
dc.subject.decs	/efectos adversos
dc.subject.decs	oncología médica
dc.subject.decs	errores de medicación
dc.relation.publishversion	https://link.springer.com/article/10.1007/s12094-018-1945-x
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.authoraffiliation	[Vera R] Servicio de Oncología Médica, Complejo Hospitalario de Navarra, Calle Irunlarrea, 3, 31008 Pamplona, Navarra, Spain. [Otero MJ] Instituto para el Uso Seguro de los Medicamentos (ISMP-España), Servicio de Farmacia Hospitalaria, Hospital Universitario de Salamanca, Salamanca, Spain. [Ayala de la Peña F] Servicio de Hematología y Oncología Médica, Hospital General Universitario Morales Meseguer, Murcia, Spain. [González-Pérez C] Servicio de Farmacia Hospitalaria, Hospital Clínico San Carlos, Madrid, Spain. [Peñuelas Á] Direcció d’Infermeria, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Enfermería Ensayos Clínicos, Vall d’Hebron Institute de Oncology, Barcelona, Spain. [Sepúlveda JM] Servicio de Oncología Médica, Hospital Universitario Doce de Octubre, Madrid, Spain. [Gorgas MQ] Farmàcia, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid	30298467
dc.identifier.wos	000461394500009
dc.rights.accessrights	info:eu-repo/semantics/openAccess